NL192739B - £3H|-imidazo-£5,1-d|-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze derivaten bevatten. - Google Patents

£3H|-imidazo-£5,1-d|-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze derivaten bevatten.

Info

Publication number
NL192739B
NL192739B NL8203286A NL8203286A NL192739B NL 192739 B NL192739 B NL 192739B NL 8203286 A NL8203286 A NL 8203286A NL 8203286 A NL8203286 A NL 8203286A NL 192739 B NL192739 B NL 192739B
Authority
NL
Netherlands
Prior art keywords
derivatives
tetrazine
imidazo
pharmaceutical compositions
compositions containing
Prior art date
Application number
NL8203286A
Other languages
English (en)
Other versions
NL192739C (nl
NL8203286A (nl
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Publication of NL8203286A publication Critical patent/NL8203286A/nl
Publication of NL192739B publication Critical patent/NL192739B/nl
Application granted granted Critical
Publication of NL192739C publication Critical patent/NL192739C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NL8203286A 1981-08-24 1982-08-23 £3H|-imidazo-£5,1-d|-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze derivaten bevatten. NL192739C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24
GB8125791 1981-08-24

Publications (3)

Publication Number Publication Date
NL8203286A NL8203286A (nl) 1983-03-16
NL192739B true NL192739B (nl) 1997-09-01
NL192739C NL192739C (nl) 1998-01-06

Family

ID=10524141

Family Applications (2)

Application Number Title Priority Date Filing Date
NL8203286A NL192739C (nl) 1981-08-24 1982-08-23 £3H|-imidazo-£5,1-d|-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze derivaten bevatten.
NL990010C NL990010I2 (nl) 1981-08-24 1999-04-01 Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze d erivaten bevatten.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL990010C NL990010I2 (nl) 1981-08-24 1999-04-01 Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze d erivaten bevatten.

Country Status (29)

Country Link
JP (1) JPS5843975A (nl)
KR (1) KR890000094B1 (nl)
AT (1) AT380256B (nl)
AU (1) AU571430B2 (nl)
BE (1) BE894175A (nl)
CA (1) CA1197247A (nl)
CH (1) CH655114A5 (nl)
DE (2) DE3231255A1 (nl)
DK (1) DK161147C (nl)
ES (1) ES8400438A1 (nl)
FI (1) FI73434C (nl)
FR (1) FR2511679A1 (nl)
GB (1) GB2104522B (nl)
GE (1) GEP19960641B (nl)
GR (1) GR76863B (nl)
HU (1) HU186107B (nl)
IE (1) IE53408B1 (nl)
IL (1) IL66606A (nl)
IT (1) IT1152505B (nl)
LT (1) LT2436B (nl)
LU (1) LU84347A1 (nl)
LV (2) LV5511A3 (nl)
NL (2) NL192739C (nl)
NZ (1) NZ201668A (nl)
OA (1) OA07174A (nl)
SE (1) SE448543B (nl)
SU (1) SU1447284A3 (nl)
UA (1) UA5971A1 (nl)
ZA (1) ZA826120B (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
FR2531958B1 (fr) * 1982-08-17 1986-10-31 May & Baker Ltd Nouveaux derive
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
CA2552095A1 (en) 2003-12-30 2005-07-14 Chemagis Ltd. Novel crystalline forms of temozolomide
MX2007008781A (es) 2005-01-21 2007-09-11 Astex Therapeutics Ltd Compuestos farmaceuticos.
PE20080695A1 (es) 2006-04-27 2008-06-28 Banyu Pharma Co Ltd Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel
JP2008081492A (ja) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd オーロラａ選択的阻害作用を有する新規アミノピリジン誘導体
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
JP5528807B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
EP2213673B1 (en) 2007-10-23 2013-06-05 Msd K.K. Pyridone-substituted-dihydropyrazolopyrimidinone derivative
PE20091101A1 (es) * 2007-12-18 2009-07-26 Pharminox Ltd AMIDAS DE ACIDO 3-SUBSTITUIDO-4-OXO-3,4-DIHIDRO-IMIDAZO[5,1-d] [1,2,3,5-TETRACINA-8-CARBOXILICO Y SU EMPLEO
JP2012509868A (ja) * 2008-11-24 2012-04-26 リライアンス ライフ サイエンシズ ピーヴィーティー リミティッド テトラジン誘導体の製造方法
EP2403339B1 (en) 2009-03-06 2017-01-18 Merck Sharp & Dohme Corp. Combination cancer therapy with an akt inhibitor and other anticancer agents
BRPI1011822A2 (pt) 2009-06-23 2016-03-29 Pharminox Ltd "compostos de 3-substituída-8-substituída-3h-imidazo[5,1-d][1,2,3,5-tetrazin-4-ona e sua aplicação"
RU2462466C1 (ru) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Замещенные азоло[1,2,4,5]тетразины - ингибиторы актинобактериальных серин-треониновых протеинкиназ
EP2766041B1 (en) 2011-10-12 2018-12-05 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
WO2017157825A1 (en) 2016-03-15 2017-09-21 F. Hoffmann-La Roche Ag Combinations of lsd1 inhibitors for use in the treatment of solid tumors
KR101847342B1 (ko) * 2017-05-08 2018-04-11 (주)센텍코리아 웨어러블 체지방 연소량 측정기

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (de) * 1979-08-09 1981-02-26 Basf Ag Azolo- eckige klammer auf 5,1-d eckige klammer zu - eckige klammer auf 1,2,3,5 eckige klammer zu -tetrazin-4-one und verfahren zur herstellung dieser verbindungen

Also Published As

Publication number Publication date
NL990010I1 (nl) 1999-07-01
IL66606A (en) 1987-07-31
FI73434B (fi) 1987-06-30
ES515176A0 (es) 1983-11-01
NL192739C (nl) 1998-01-06
JPH045029B2 (nl) 1992-01-30
IT1152505B (it) 1987-01-07
FI73434C (fi) 1987-10-09
FR2511679B1 (nl) 1985-02-01
DK161147B (da) 1991-06-03
NL8203286A (nl) 1983-03-16
ZA826120B (en) 1983-07-27
DK161147C (da) 1991-11-18
HU186107B (en) 1985-06-28
NZ201668A (en) 1985-08-16
JPS5843975A (ja) 1983-03-14
IE53408B1 (en) 1988-11-09
AT380256B (de) 1986-05-12
LV5511A3 (lv) 1994-03-10
FI822921L (fi) 1983-02-25
GEP19960641B (en) 1996-11-15
IT8222938A0 (it) 1982-08-23
DE3231255C2 (nl) 1992-02-27
DE19975037I2 (de) 2001-06-13
NL990010I2 (nl) 1999-09-01
DE3231255A1 (de) 1983-03-03
ES8400438A1 (es) 1983-11-01
GR76863B (nl) 1984-09-04
LT2436B (lt) 1994-02-15
IE822026L (en) 1983-02-24
CA1197247A (fr) 1985-11-26
OA07174A (fr) 1984-04-30
IL66606A0 (en) 1982-12-31
DK377882A (da) 1983-02-25
CH655114A5 (fr) 1986-03-27
KR890000094B1 (ko) 1989-03-07
KR840001175A (ko) 1984-03-28
LU84347A1 (fr) 1983-06-07
LV5621A3 (lv) 1994-05-10
GB2104522B (en) 1985-06-12
SU1447284A3 (ru) 1988-12-23
FI822921A0 (fi) 1982-08-23
BE894175A (fr) 1983-02-23
FR2511679A1 (fr) 1983-02-25
GB2104522A (en) 1983-03-09
UA5971A1 (uk) 1994-12-29
ATA319182A (de) 1985-09-15
SE8204817D0 (sv) 1982-08-23
SE8204817L (sv) 1983-02-25
AU571430B2 (en) 1988-04-21
SE448543B (sv) 1987-03-02
AU8749382A (en) 1983-03-03

Similar Documents

Publication Publication Date Title
NL192739B (nl) £3H|-imidazo-£5,1-d|-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze derivaten bevatten.
MX9203176A (es) 1,2,4-triazolonas substituidas con fenoxietilo y composiciones farmaceuticas que las contienen.
NL192201B (nl) Farmacologisch actieve fenylaminoalkylcyclobutaanverbindingen en prepa- raten die deze verbindingen bevatten.
IT8220611A0 (it) Composizioni farmaceutiche topiche.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
ZA821403B (en) 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives and pharmaceutical compositions containing them
NL192343B (nl) 17Ó-gesubstitueerde androsta-(1,)4-(di)een-3-on-17ß-carbonzuurverbindingen met een ontstekingswerende werkzaamheid en farmaceutische preparaten, die deze verbindingen bevatten.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
IT8119673A0 (it) Composizioni farmaceutiche per il trattamento di osteopatie.
IT7927614A0 (it) 1,2,4,5-tetra-alchil-4-arilpiperidi ne e relative formulazioni farmaceutiche.
MX9203148A (es) 2,6-dialcoxipenzamidas y composiciones farmaceuticas que las contienen.
NL190451B (nl) Reukstofcompositie.
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
OA06373A (fr) Nouvelles compositions pharmaceutiques à base d'aryltrifluoroétanols.
DE3268487D1 (en) 2,3,4-trinor-m-inter-phenylene-prostaglandin derivatives, their preparation and pharmaceutical compositions
NL193317B (nl) 1,8-Diacyloxy-10-acylantronen en cosmetische en farmaceutische samenstellingen die ze bevatten.
IT1186667B (it) 2,1,3-benzotiadiazoli e 2,1,3-benzossadiazoli,loro preparazione e loro applicazione come medicamenti
NL190120C (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen alsmede farmaceutisch preparaat daarvan.
IT1208432B (it) Composizioni farmaceutiche
IT1206513B (it) Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.
FR2572933B1 (fr) Compositions pharmaceutiques topiques a base de tizanidine
BE892709A (fr) Nouvelles compositions pharmaceutiques topiques
IT8219906A0 (it) 1,2,3,4-tetraidronaftaleni sostituiti con amminoalchili ad azione farmaceutica.
IE820963L (en) Shampoo compositions.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: MBL (1991) LIMITED

CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED

AC1 Application for a supplementary protection certificate

Free format text: 990010, 19990401

KC1 Grant of a supplementary protection certificate

Free format text: 990010, 20020823, EXPIRES: 20070822

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20020823